Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms VHL-targeting PROTAC analogue 7 |
Target |
Mechanism BRD4 degraders(Bromodomain-containing protein 4 degraders), VHL inhibitors(von Hippel-Lindau tumor suppressor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC51H64ClN9O9S2 |
InChIKeyLSELSHXLKGXPPF-BOBBFQORSA-N |
CAS Registry1797406-70-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | GB | 08 Jun 2017 | |
Hematologic Neoplasms | Preclinical | US | 08 Jun 2017 | |
Solid tumor | Preclinical | GB | 08 Jun 2017 | |
Solid tumor | Preclinical | US | 08 Jun 2017 | |
Neoplasms | Preclinical | US | 16 Jun 2015 |